摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

testosterone pelargonate | 57525-67-4

中文名称
——
中文别名
——
英文名称
testosterone pelargonate
英文别名
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] nonanoate
testosterone pelargonate化学式
CAS
57525-67-4
化学式
C28H44O3
mdl
——
分子量
428.656
InChiKey
TZZDYDXNNUTGHU-FEZCWRLCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    101.4-102.8 °C
  • 沸点:
    527.6±50.0 °C(Predicted)
  • 密度:
    1.05±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    7.4
  • 重原子数:
    31
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME
    申请人:MonoSol Rx, LLC
    公开号:EP2744482A1
    公开(公告)日:2014-06-25
  • US20140255473A1
    申请人:——
    公开号:US20140255473A1
    公开(公告)日:2014-09-11
  • [EN] STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME<br/>[FR] SYSTÈMES D'ADMINISTRATION D'HORMONE STÉROÏDE ET PROCÉDÉS DE PRÉPARATION DE CEUX-CI
    申请人:MONOSOL RX LLC
    公开号:WO2013026002A1
    公开(公告)日:2013-02-21
    The present invention is directed to steroid hormone delivery systems and methods of preparing the same. In particular, the steroid hormone delivery systems provided include a primary construct having one or more hydrophobic steroid hormone esters in the form of a liposome, a lipid particle, a micelle, an emulsion or a niosome which is then formulated into a secondary construct for administration. Exemplary secondary constructs include a film for sublingual or buccal administration.
  • [EN] STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME<br/>[FR] SYSTÈMES D'ADMINISTRATION D'HORMONES STÉROÏDES ET PROCÉDÉS DE PRÉPARATION DE CEUX-CI
    申请人:MONOSOL RX LLC
    公开号:WO2014144366A1
    公开(公告)日:2014-09-18
    The present invention is directed to film dosage compositions for delivery of testosterone esters. In particular, a film dosage composition is provided that includes: a) a polymeric matrix and b) a plurality of particles including: i) a testosterone ester and ii) a surfactant. A film dosage composition is also provided that includes: a) a first region including: i) a first polymeric matrix and ii) a first plurality of particles including: 1) a first testosterone ester and 2) a first surfactant; and b) a second region including: i) a second polymeric matrix and ii) a second plurality of particles including: 1) a second testosterone ester and 2) a second surfactant.
查看更多